
Infection in Pulmonary Vascular Disease (iPVD) Consortium

The Infection in Pulmonary Vascular Disease (iPVD) Consortium’s primary focus is to enhance awareness about the role of infection on PVD, and foster research collaborations in infectious diseases covering basic science, translational and clinical aspects, aiming to better understand its mechanisms and global impact.
Symposia & Conferences
The iPVD consortium annual meetings are usually held as a pre-conference session during the annual PVRI meeting. This meeting brings together researchers and clinicians from around the world to share their latest findings on the pathogenesis, diagnosis, and treatment of infectious pulmonary vascular diseases. The meeting covers a wide range of topics, including:
• The epidemiology and risk factors for infectious pulmonary vascular diseases
• The molecular mechanisms by which infections trigger and worsen pulmonary vascular disease.
• New diagnostic tools and biomarkers for infectious pulmonary vascular diseases
• Emerging therapeutic strategies for infectious pulmonary vascular diseases
Virtual Symposia by the iPVD Consortium
Another successful output of the iPVD Consortium is its Virtual Symposium webinar series, which has continued into 2024 after delivering six webinars on inflammation and infection in 2023. The series, hosted by PVRI, is a global education programme highlighting the latest research on infections in PVD. The webinars provide a great opportunity for international speakers to participate, present, and ask questions of our fantastic committee. Webinars are held on the last Wednesday of the month at 15:00 BST/GMT, and recordings are available on our website.
The Microbes webinar series
- Microbiome and microbial metabolites, March 2024
- Bacteria, May 2024
- Clinical Aspects, August 2024
- Co-Infection and Pulmonary Vascular Disease, November 2024
Other webinars
- Perspectives on global epidemiology challenges, February 2025
- Register for free: Pulmonary Hypertension in the Shadow of Infections: Challenges in Indian Practice, August 2025
Publications
- Infection and pulmonary vascular diseases consortium: United against a global health challenge, Suellen Oliveira, Sharilyn Almodóvar, Ghazwan Butrous, Vinicio De Jesus Perez, Alexandre Fabro, Brian Graham, Ana Mocumbi, Peter Nyasulu, Olga Tura-Ceide, Rudolf Oliveira, Navneet Dhillon. Pulmonary Circulation, Nov 2024.
- Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities, Rahul Kumar, Öznur Aktay-Cetin, Vaughn Craddock, Daniel Morales-Cano, Djuro Kosanovic, Angel Cogolludo, Francisco Perez-Vizcaino, Sergey Avdeev, Ashok Kumar, Anil Kumar Ram, Stuti Agarwal, Ananya Chakraborty, Rajkumar Savai, Vinicio de Jesus Perez, Brian Graham, Ghazwan Butrous, Navneet Dhillon. PLoS Pathog, Jan 2023.
- Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges, Rudolf Oliveira, Peter Nyasulu, Adeel Ahmed Iqbal, Muhammad Hamdan Gul, Eloara Ferreira, John William Leclair, Zin Mar Htun, Luke Howard, Ana Mocumbi, Andrew Bryant, Jacques Tamuzi, Sergey Avdeev, Nicola Petrosillo, Ahmed Hassan, Ghazwan Butrous, Vinicio de Jesus Perez. Front Med (Lausanne), Nov 2022.
- Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective, Sarah Halawa, Soni Pullamsetti, Charles Bangham, Kurt Stenmark, Peter Dorfmüller, Maria Frid, Ghazwan Butrous, Nick Morrell, Vinicio de Jesus Perez, David Stuart, Kevin O'Gallagher, Ajay Shah, Yasmine Aguib, Magdi Yacoub. Nat Rev Cardiol. May 2022.
Find out more about iPVD consortium. If you are interested in joining this Task Force, please get in touch.